Cabozantinib shows promise as first line treatment for differentiated thyroid cancer
A kinase inhibitor called cabozantinib could be a viable therapy option for patients with metastatic, radioactive iodine-resistant thyroid cancer...
List view / Grid view
A kinase inhibitor called cabozantinib could be a viable therapy option for patients with metastatic, radioactive iodine-resistant thyroid cancer...
The FDA has approved Biktarvy a once-daily single-tablet regimen for the treatment of HIV-1 infection...
A study suggests long-term inhaled corticosteroids (ICS) in patients with COPD may increase the risk of bone fractures in both men and women...
Researchers have shown that two different compounds can safely and effectively be added to treatment regimens to block the transmission of the most common form of malaria...
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested...
In a new study, researchers have developed a new method for producing medicine on a white edible material containing a QR code that contains the medical drug...
Researchers have successfully applied a novel combination therapy to restore skin colour in patients with vitiligo...
Injecting minute amounts of two immune-stimulating agents directly into solid tumours in mice can eliminate all traces of cancer...
The FDA has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate...
Physicians have reported the first paediatric use of pyridostigmine to reverse complications from botulinum toxin therapy...
The FDA has approved Lutathera for the treatment of a type of cancer that affects the pancreas the gastrointestinal tract...
The EMA has recommended granting a marketing authorisation in the EU for Lamzede a long-term enzyme replacement therapy for alpha-mannosidosis...
A drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus...
A drug used to treat seizures may effectively treat the movement symptoms in people with dementia with Lewy bodies without causing additional psychiatric symptoms...
Treatment with a pharmaceutical formulation of cannabidiol alongside other anti-epilepsy treatments helped to reduce the number of drop seizures in people with Lennox-Gastaut syndrome...